Facebook Twitter LinkedIn Instagram Email Printer Google Plus


A digital tool to humanize care is helping clinicians use empathy to transform care delivery.

CEO, PatientWisdom/NRC Health

Predictions on the modernization and ultimately transformation of care in the home.

Senior Vice President, Highmark Health
Partner, Health and Life Sciences, Oliver Wyman

Experts predict healthcare's "new normal" will come in late 2021. This webinar explores questions leaders must ask today to stay resilient tomorrow.

Co-Founder and CEO, Alpha Health
Partner, Health and Life Sciences, Oliver Wyman

Q&A with Landmark Health on Their Pandemic Strategy

Lessons for healthcare leaders on caring for an especially vulnerable senior population.

Chief Medical Officer, Landmark Health
Director, Strategy & Corporate Development, Landmark Health
Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman

Executives discuss the COVID-19 financial fallout and what future subsequent peaks might look like for health systems.

Insights in your inbox


Seven ways people "hire" telemedicine to improve their health and well-being.

President and CEO of Envision Genomics, Chair-Elect of AMGA, Vice-Chair of HHS' PTAC
Engage Consumers September 05, 2019

Let the Data Flow

We're at the tipping point of consumer data transformation. We just have to want to share this data, not hold onto it for ourselves.

VP of Products, HeathSparq

New competitors in healthcare are multiplying and scaling. But what will it take to win?

Director of Innovation, Atrium Health

Innovator-Led Innovations May Soon Come True

Healthcare leaders demand disruption, but who will spark big change first?

President and CEO, Business Group on Health
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox